↓ Skip to main content

Diabetes - Perspectives in Drug Therapy

Overview of attention for book
Cover of 'Diabetes - Perspectives in Drug Therapy'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Targeting type 2 diabetes.
  3. Altmetric Badge
    Chapter 2 Dual acting and pan-PPAR activators as potential anti-diabetic therapies.
  4. Altmetric Badge
    Chapter 3 GLP-1 agonists and dipeptidyl-peptidase IV inhibitors.
  5. Altmetric Badge
    Chapter 4 Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes.
  6. Altmetric Badge
    Chapter 5 SGLT inhibitors as new therapeutic tools in the treatment of diabetes.
  7. Altmetric Badge
    Chapter 6 Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy.
  8. Altmetric Badge
    Chapter 7 Nampt and its potential role in inflammation and type 2 diabetes.
  9. Altmetric Badge
    Chapter 8 Inhibition of ganglioside biosynthesis as a novel therapeutic approach in insulin resistance.
  10. Altmetric Badge
    Chapter 9 Overcoming Insulin Resistance with Ciliary Neurotrophic Factor
  11. Altmetric Badge
    Chapter 10 Thermogenesis and related metabolic targets in anti-diabetic therapy.
  12. Altmetric Badge
    Chapter 11 Interleukin-targeted therapy for metabolic syndrome and type 2 diabetes.
  13. Altmetric Badge
    Chapter 12 Fructose-1, 6-bisphosphatase inhibitors for reducing excessive endogenous glucose production in type 2 diabetes.
  14. Altmetric Badge
    Chapter 13 AMP-activated protein kinase and metabolic control.
  15. Altmetric Badge
    Chapter 14 Mitochondria as potential targets in antidiabetic therapy.
  16. Altmetric Badge
    Chapter 15 Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects.
  17. Altmetric Badge
    Chapter 16 Erratum to Chapter 11: Interleukin-Targeted Therapy for Metabolic Syndrome and Type 2 Diabetes
Attention for Chapter 12: Fructose-1, 6-bisphosphatase inhibitors for reducing excessive endogenous glucose production in type 2 diabetes.
Altmetric Badge

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
34 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Fructose-1, 6-bisphosphatase inhibitors for reducing excessive endogenous glucose production in type 2 diabetes.
Chapter number 12
Book title
Diabetes - Perspectives in Drug Therapy
Published in
Handbook of experimental pharmacology, January 2011
DOI 10.1007/978-3-642-17214-4_12
Pubmed ID
Book ISBNs
978-3-64-217213-7, 978-3-64-217214-4
Authors

Paul D. van Poelje, Scott C. Potter, Mark D. Erion

Editors

Prof.Dr.Dr. Mathias Schwanstecher

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Mexico 1 3%
Spain 1 3%
India 1 3%
Unknown 30 88%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 32%
Researcher 5 15%
Student > Bachelor 3 9%
Unspecified 2 6%
Student > Ph. D. Student 2 6%
Other 4 12%
Unknown 7 21%
Readers by discipline Count As %
Agricultural and Biological Sciences 6 18%
Pharmacology, Toxicology and Pharmaceutical Science 6 18%
Medicine and Dentistry 5 15%
Immunology and Microbiology 3 9%
Unspecified 2 6%
Other 5 15%
Unknown 7 21%